Pier Capital, LLC Personalis, Inc. Transaction History

Pier Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$12.24 - $21.25 $3.71 Million - $6.43 Million	-302,786 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$16.69 - $26.05 $130,682 - $203,971	-7,830 Reduced 2.52%	302,786 $5.83 Million
Q2 2021 Aug 12, 2021	BUY	$18.15 - $27.75 $97,229 - $148,656	5,357 Added 1.75%	310,616 $7.86 Million
Q1 2021 May 13, 2021	BUY	$20.71 - $51.02 $96,073 - $236,681	4,639 Added 1.54%	305,259 $7.51 Million
Q4 2020 Feb 16, 2021	BUY	$21.84 - $44.0 $6.57 Million - $13.2 Million	300,620 New	300,620 $11 Million

30.1M

27.5K

85.4K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $264M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pier Capital, LLC with notifications on news.